Floxacillin sodium

氟氯西林钠

Report date: 2022/05/19 14:21:42
NME

Base Information

Drug NameFloxacillin sodium
Drug Alias Name氟氯青霉素flucloxacillineFlucloxacillin sodium氟氯唑青霉素flucloxacillinum +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsRenal Insufficiency, ChronicCellulitisBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryMainland China
Original Approved Date2002/04/17
Country/TerritoryBelgiumDenmarkGermany +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Southern DenmarkBright Future Pharmaceuticals FactoryUniversity Of Southampton
Inactive CompaniesGlaxosmithkline PlcUniversitaire Ziekenhuizen Leuven
Active IndicationsCellulitisBacterial Infections
Inactive IndicationsRenal Insufficiency, Chronic

Other Information

ATC CodeJ01CF05
Related LinksWikipediaDrugBankKEGG